Spectral Med Stock Performance
| EDTXF Stock | USD 1.00 0.01 0.99% |
The entity has a beta of 0.0067, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Spectral Med's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spectral Med is expected to be smaller as well. At this point, Spectral Med has a negative expected return of -0.0736%. Please make sure to validate Spectral Med's skewness, day typical price, as well as the relationship between the value at risk and jensen alpha , to decide if Spectral Med performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Spectral Med has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Spectral Med is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 5.8 M | |
| Total Cashflows From Investing Activities | -325 K |
Spectral |
Spectral Med Relative Risk vs. Return Landscape
If you would invest 110.00 in Spectral Med on October 19, 2025 and sell it today you would lose (10.00) from holding Spectral Med or give up 9.09% of portfolio value over 90 days. Spectral Med is currently producing negative expected returns and takes up 4.0452% volatility of returns over 90 trading days. Put another way, 36% of traded pink sheets are less volatile than Spectral, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Spectral Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectral Med's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Spectral Med, and traders can use it to determine the average amount a Spectral Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0182
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EDTXF |
Based on monthly moving average Spectral Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spectral Med by adding Spectral Med to a well-diversified portfolio.
Spectral Med Fundamentals Growth
Spectral Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Spectral Med, and Spectral Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectral Pink Sheet performance.
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Current Valuation | 65.99 M | |||
| Shares Outstanding | 278.22 M | |||
| Price To Earning | (13.69) X | |||
| Price To Book | 51.73 X | |||
| Price To Sales | 42.75 X | |||
| Revenue | 2.05 M | |||
| EBITDA | (8.46 M) | |||
| Cash And Equivalents | 3.47 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 537 K | |||
| Debt To Equity | 0.26 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.7 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 11.55 M | |||
| Retained Earnings | (51.99 M) | |||
| Current Asset | 6.33 M | |||
| Current Liabilities | 1.96 M | |||
About Spectral Med Performance
By analyzing Spectral Med's fundamental ratios, stakeholders can gain valuable insights into Spectral Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spectral Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spectral Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people.Things to note about Spectral Med performance evaluation
Checking the ongoing alerts about Spectral Med for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Spectral Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectral Med generated a negative expected return over the last 90 days | |
| Spectral Med has some characteristics of a very speculative penny stock | |
| Spectral Med has high historical volatility and very poor performance | |
| The company reported the revenue of 2.05 M. Net Loss for the year was (8.79 M) with profit before overhead, payroll, taxes, and interest of 1.22 M. | |
| Spectral Med has accumulated about 3.47 M in cash with (8.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 20.0% of the company shares are held by company insiders |
- Analyzing Spectral Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectral Med's stock is overvalued or undervalued compared to its peers.
- Examining Spectral Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectral Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectral Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectral Med's pink sheet. These opinions can provide insight into Spectral Med's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spectral Pink Sheet analysis
When running Spectral Med's price analysis, check to measure Spectral Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectral Med is operating at the current time. Most of Spectral Med's value examination focuses on studying past and present price action to predict the probability of Spectral Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectral Med's price. Additionally, you may evaluate how the addition of Spectral Med to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |